As of 2026-04-10, the EV/EBITDA ratio of G1 Therapeutics Inc (GTHX) is -11.57. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GTHX's latest enterprise value is 406.48 mil USD. GTHX's TTM EBITDA according to its financial statements is -35.15 mil USD. Dividing these 2 quantities gives us the above GTHX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.3x - 15.5x | 14.5x |
| Forward P/E multiples | 15.9x - 20.2x | 18.2x |
| Fair Price | (11.13) - (10.87) | (11.45) |
| Upside | -255.7% - -252.0% | -260.1% |
| Date | EV/EBITDA |